期刊文献+

复尔凯鼻肠管肠内营养支持在胃癌治疗中的应用 被引量:2

Application of flocare nasointestinal tube enteral nutrition support in the the treatment of gastric cancer
下载PDF
导出
摘要 目的:探讨复尔凯鼻肠管肠内营养支持在胃癌治疗中的应用。方法回顾性分析本院外科收治胃癌患者136例,并行胃癌根治术、术中放置复尔凯鼻肠营养管,术后予以肠内营养支持治疗的临床资料。结果本组患者行根治性远端胃切除术,其中行毕Ⅰ式吻合64例,毕Ⅱ式吻合38例;根治性近端胃切除术22例,全胃切除术12例。所有患者均在术后第2~4天肛门排气、排便,术后恢复良好,无吻合口瘘、十二指肠残端瘘及相关并发症的发生。全组病例中无一例死亡。结论对于胃癌患者,术中置入复尔凯鼻肠营养管,术后早期给予肠内营养,操作简单,方便可行,术后恢复快,并发症及死亡率低,值得推广。 Objective To explore the clinical value of enteral flocare nasointestinal tube nutrition support in the treatment of gastric cancer. Methods The clinical data of 136 gastric cancer patients from 2009 to 2012 were retrospectively analyzed, which were treated with radical operation and placed flocare nasointestinal tube, and given enteral nutrition support after the operation. Results This group of patients with an average age of 60 years old, male and female ratio was 10:7;radical distal gastrectomy, 64 cases with billroth I gastrectomy, 38 cases with billroth II gastrectomy;22 cases with radical proximal gastrectomy, 12 cases with total gastrectomy. All patients were 2~4 days after surgery the anus exhaust and defecate, recovered well postoperatively, no anastomotic fistula, duodenal stump fistula and related complications. no one died. Conclusion For gastric cancer patients, intraoperative placement after Flocare nasointestinal tube, enteral nutrition for early postoperative, the operation is simple, convenient and feasible with fast recovery, low complications and mortality rate, so it is worthy clinical promotion.
出处 《中国现代药物应用》 2014年第11期54-55,共2页 Chinese Journal of Modern Drug Application
关键词 复尔凯鼻肠管 胃癌 肠内营养 外科治疗 Flocare nasointestinal tube Gastric cancer Enteral nutrition Surgical treatment
  • 相关文献

参考文献3

二级参考文献13

  • 1[1]Fanelli FR,Cascino A,Muscaritoli M.Abnormal substrate metab olism and nutritional strategies in cancer management[J].JPEN,1991,15(6):680-683.
  • 2[2]Tisdale MJ.Cancer cachexia.Metabolic alterations and clinical manifestations[J].Nutrition,1997,13(1):1-7.
  • 3[3]Hollander DM,Ebert EC,Roberts AI,et al.Effects of tumor type and burden on carcass lipid depletion in mice[J].Surgery,1986,100:292-295.
  • 4[4]Bozzetti F.Nutritional support in the adult cancer patient[J].Clinical Nutrition,1992,11:167-179.
  • 5[5]Holroyde CP,Reichard GA.Carbohydrate metabolism in cancer cachexia[J].Cancer Treat Rep,1981.65(suppl 5):55-60.
  • 6[6]Rofe AM,Bourgeosis CS,Coyle P,et al.Altered insulin response to glucose in weight-losing cancer patients[J].Anticancer Res,1994,4:647.
  • 7[7]Oliff A,Defo-Jones D,Boyer M,et al.Tumors secreting human TNF/cachectin induce cachexia in mice[J].Cell,1987,50:555.
  • 8[8]Laviano A,Meguid MM,Renvyle T,et al.Relationship between inter leukin-1 and cancer anorexia[J].Nutrition,1995,11:680.
  • 9[9]Strassmann G,Fong M,Kenney JS,et al.Evidence for the involvement of interleukin 6 in experimental cancer cachexia[J].J Clin Invest,1992,89:1681.
  • 10[10]Thanhauser A,Reiling N,Bohle A,et al.Pentoxifyline:a potent inhibitor of IL-2 and IFN-γ biosynthesis and BCG-induced cytotoxicity[J].Immunology,1993,80:151.

共引文献100

同被引文献7

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部